Suppr超能文献

窦性心动过缓患者中早期与晚期房颤导管消融与永久性心脏起搏器植入风险。

Early Versus Late Catheter Ablation of Atrial Fibrillation and Risk of Permanent Pacemaker Implantation in Patients With Underlying Sinus Node Dysfunction.

机构信息

Department of Cardiology New York University Langone Health New York NY.

Heart and Vascular Institute MetroHealth Medical Center/Case Western Reserve University Cleveland OH.

出版信息

J Am Heart Assoc. 2022 Sep 6;11(17):e023333. doi: 10.1161/JAHA.121.023333. Epub 2022 Sep 3.

Abstract

Background Atrial fibrillation (AF) is associated with anatomical and electrical remodeling. Some patients with AF have concomitant sick sinus syndrome and may need permanent pacemaker (PPM) implantation. Association between catheter ablation of AF timing and need for PPM in sick sinus syndrome has not been assessed. Methods and Results We used pooled electronic health data to perform retrospective cross-sectional analysis of 66,  595 patients with AF and sick sinus syndrome to assess the need of PPM implantation temporally, with AF performed divided into earlier within 5 years (group 1), 5 to 10 years (group 2), or beyond 10 years (group 3) of diagnosis. PPM implantation was lowest among those who had catheter ablation within 5 years of sick sinus syndrome diagnosis: group 1 versus group 2 (18.15% versus 27.21%) and group 1 versus group 3 (18.15% versus 27.22%). Interestingly, there was no difference in risk of PPM between group 2 and group 3 (27.21% versus 27.22%; odds ratio [OR], 1.00 [95% CI, 0.85-1.20]). Conclusions Even after controlling known risk factors that increase the need for pacemaker implantation, timing of AF ablation was the strongest predictor for need for PPM. Patients adjusted OR of PPM was lower if patients had catheter ablation within 5 years of diagnosis compared with later than 5 years (adjusted OR, 0.64 [95% CI, 0.59-0.70]).

摘要

背景

心房颤动(AF)与解剖和电重构有关。一些 AF 患者伴有病态窦房结综合征,可能需要植入永久性起搏器(PPM)。尚未评估 AF 导管消融与病态窦房结综合征中 PPM 需求之间的关联。

方法和结果

我们使用汇总的电子健康数据对 66595 例 AF 和病态窦房结综合征患者进行回顾性横断面分析,以评估 PPM 植入的时间需求,将 AF 分为 5 年内(第 1 组)、5 至 10 年内(第 2 组)或 10 年以上(第 3 组)。在病态窦房结综合征诊断后 5 年内进行导管消融的患者中,PPM 植入率最低:第 1 组与第 2 组(18.15%比 27.21%)和第 1 组与第 3 组(18.15%比 27.22%)。有趣的是,第 2 组和第 3 组之间 PPM 的风险无差异(27.21%比 27.22%;优势比[OR],1.00[95%CI,0.85-1.20])。

结论

即使控制了增加起搏器植入需求的已知危险因素,AF 消融的时机仍然是 PPM 需求的最强预测因素。与 5 年以后相比,如果患者在诊断后 5 年内进行导管消融,则患者 PPM 的调整 OR 较低(调整 OR,0.64[95%CI,0.59-0.70])。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/9496447/8a8d2aec68dc/JAH3-11-e023333-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验